论文部分内容阅读
目的:观察尤瑞克林联合依达拉奉治疗大面积脑梗塞的临床疗效。方法:将30例大面积脑梗塞患者随机分为观察组和对照组各15例,在采用脑梗塞常规治疗的基础上,对照组应用依达拉奉,观察组在对照组的基础上,采用尤瑞克林联合依达拉奉联合治疗,观察比较两组治疗前后的神经功能缺损评分和临床疗效。结果:观察组治疗后神经功能缺损程度评分显著低于对照组(P<0.05);观察组总有效率为86.7%,与对照组总有效率(60.0%)比较有显著性差异(P<0.05)。结论:尤瑞克林联合依达拉奉治疗大面积脑梗塞临床疗效明显优于依达拉奉单独用药治疗,可广泛应用于临床。
Objective: To observe the curative effect of uracil combined with edaravone in treating large area cerebral infarction. Methods: Thirty patients with large area cerebral infarction were randomly divided into observation group and control group, 15 cases were treated with edaravone in the control group on the basis of routine treatment of cerebral infarction. On the basis of the control group, Urexinlin combined edaravone combined treatment, observation and comparison of the two groups before and after treatment of neurological deficit score and clinical efficacy. Results: The score of neurological impairment in observation group was significantly lower than that in control group (P <0.05). The total effective rate in observation group was 86.7%, which was significantly lower than that in control group (60.0%) (P <0.05) ). Conclusion: The combination of erilachlor and edaravone is superior to Edaravone in the treatment of large area cerebral infarction. It can be widely used in clinic.